Effect of Tranexamic Acid (TXA) on Reduction of Postoperative Blood Transfusion

Summary

Tranexamic Acid (TXA) is an antifibrolytic medication used in total hip and knee arthroplasty to reduce the need for intraoperative and postoperative blood transfusions. Limited research is available on its use in hip fracture patients. We hypothesize that the use of TXA preoperatively, perioperatively, and postoperatively will decrease blood loss and need for blood transfusion postoperatively.

Timeline

Start

2017-08-30

Primary completion

2027-07-01

Completion

2027-09-01

Drugs

Indications

No indication recorded.